Related Experiment Video
Updated: Apr 12, 2026
08:41
Carotid Artery Infusions for Pharmacokinetic and Pharmacodynamic Analysis of Taxanes in Mice
Published on: October 27, 2014
24.2K
Inter-patient variability in docetaxel pharmacokinetics: A review
Annemieke J M Nieuweboer1, Ellen S de Morrée2, Anne-Joy M de Graan1
1Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Cancer Treatment Reviews
|May 19, 2015
Summary
Docetaxel dosing is complex due to high variability in how patients process the drug. This review details factors like liver function and drug interactions that affect docetaxel pharmacokinetics for better treatment.
Area of Science:
- Oncology
- Pharmacology
- Clinical Pharmacy
Background:
- Docetaxel is a key chemotherapy for solid tumors.
- Significant inter-individual variability (IIV) in docetaxel pharmacokinetics (PK) complicates optimal dosing.
- Understanding factors influencing docetaxel PK is crucial for efficacy and safety.
Purpose of the Study:
- To review clinically relevant factors affecting docetaxel pharmacokinetics.
- To provide insights for optimizing docetaxel dosage in individual cancer patients.
Main Methods:
- Literature review of studies on docetaxel pharmacokinetics.
- Focus on factors with established clinical relevance.
- Analysis of drug interactions and patient-specific variables.
Main Results:
- Liver impairment significantly reduces docetaxel clearance, necessitating dosage adjustments.
- Co-administration with strong CYP3A4 inhibitors (e.g., ketoconazole) decreases docetaxel clearance.
- Gender, castration, and menopausal status may influence docetaxel PK, though pharmacogenetics currently has limited clinical impact.
Conclusions:
- Clinically relevant factors like liver function and drug interactions must guide docetaxel dosing.
- Further research is needed to fully elucidate docetaxel PK variability.
- Personalized dosing strategies are essential for improving docetaxel treatment outcomes.
Related Concept Videos
01:24Dosage Regimen: Individualization
369
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
369
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
349
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
349
01:24Pharmacokinetic–Pharmacodynamic Relationship: Problems
101
The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...
101
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
330
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
330
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
351
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
351
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
343
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
343